BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37031741)

  • 1. Advanced translational PBPK model for transferrin receptor-mediated drug delivery to the brain.
    Sato S; Liu S; Goto A; Yoneyama T; Okita K; Yamamoto S; Hirabayashi H; Iwasaki S; Kusuhara H
    J Control Release; 2023 May; 357():379-393. PubMed ID: 37031741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a translational physiologically-based pharmacokinetic (PBPK) model for receptor-mediated transcytosis of anti-transferrin receptor monoclonal antibodies in the central nervous system.
    Chang HY; Wu S; Chowdhury EA; Shah DK
    J Pharmacokinet Pharmacodyn; 2022 Jun; 49(3):337-362. PubMed ID: 35092540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis.
    Chang HY; Wu S; Li Y; Zhang W; Burrell M; Webster CI; Shah DK
    MAbs; 2021; 13(1):1874121. PubMed ID: 33499723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity.
    Haqqani AS; Thom G; Burrell M; Delaney CE; Brunette E; Baumann E; Sodja C; Jezierski A; Webster C; Stanimirovic DB
    J Neurochem; 2018 Sep; 146(6):735-752. PubMed ID: 29877588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Design of Anti-Transferrin Receptor Bispecific Antibodies for Optimal Delivery into the Human Brain.
    Kanodia JS; Gadkar K; Bumbaca D; Zhang Y; Tong RK; Luk W; Hoyte K; Lu Y; Wildsmith KR; Couch JA; Watts RJ; Dennis MS; Ernst JA; Scearce-Levie K; Atwal JK; Ramanujan S; Joseph S
    CPT Pharmacometrics Syst Pharmacol; 2016 May; 5(5):283-91. PubMed ID: 27299941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VHHs as tools for therapeutic protein delivery to the central nervous system.
    Wouters Y; Jaspers T; Rué L; Serneels L; De Strooper B; Dewilde M
    Fluids Barriers CNS; 2022 Oct; 19(1):79. PubMed ID: 36192747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mathematical PKPD and safety model of bispecific TfR/BACE1 antibodies for the optimization of antibody uptake in brain.
    Gadkar K; Yadav DB; Zuchero JY; Couch JA; Kanodia J; Kenrick MK; Atwal JK; Dennis MS; Prabhu S; Watts RJ; Joseph SB; Ramanujan S
    Eur J Pharm Biopharm; 2016 Apr; 101():53-61. PubMed ID: 26820920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Delivery of Galanin Conjugates to the Brain through Bioengineering of the Anti-Transferrin Receptor Antibody OX26.
    Thom G; Burrell M; Haqqani AS; Yogi A; Lessard E; Brunette E; Delaney C; Baumann E; Callaghan D; Rodrigo N; Webster CI; Stanimirovic DB
    Mol Pharm; 2018 Apr; 15(4):1420-1431. PubMed ID: 29485883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apicobasal transferrin receptor localization and trafficking in brain capillary endothelial cells.
    Nielsen SSE; Holst MR; Langthaler K; Christensen SC; Bruun EH; Brodin B; Nielsen MS
    Fluids Barriers CNS; 2023 Jan; 20(1):2. PubMed ID: 36624498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the transferrin receptor for brain drug delivery.
    Johnsen KB; Burkhart A; Thomsen LB; Andresen TL; Moos T
    Prog Neurobiol; 2019 Oct; 181():101665. PubMed ID: 31376426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Perfused In Vitro Human iPSC-Derived Blood-Brain Barrier Faithfully Mimics Transferrin Receptor-Mediated Transcytosis of Therapeutic Antibodies.
    Burgio F; Gaiser C; Brady K; Gatta V; Class R; Schrage R; Suter-Dick L
    Cell Mol Neurobiol; 2023 Nov; 43(8):4173-4187. PubMed ID: 37698826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting nanoparticle technology for blood-brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes.
    Johnsen KB; Moos T
    J Control Release; 2016 Jan; 222():32-46. PubMed ID: 26658072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor.
    Wiley DT; Webster P; Gale A; Davis ME
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8662-7. PubMed ID: 23650374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin Receptor-Mediated Uptake at the Blood-Brain Barrier Is Not Impaired by Alzheimer's Disease Neuropathology.
    Bourassa P; Alata W; Tremblay C; Paris-Robidas S; Calon F
    Mol Pharm; 2019 Feb; 16(2):583-594. PubMed ID: 30609376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and modulation of the transferrin receptor on brain capillary endothelial cells.
    Visser CC; Voorwinden LH; Crommelin DJ; Danhof M; de Boer AG
    Pharm Res; 2004 May; 21(5):761-9. PubMed ID: 15180331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized Preclinical
    Morrison JI; Petrovic A; Metzendorf NG; Rofo F; Yilmaz CU; Stenler S; Laudon H; Hultqvist G
    Mol Pharm; 2023 Mar; 20(3):1564-1576. PubMed ID: 36808999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice.
    Manich G; Cabezón I; del Valle J; Duran-Vilaregut J; Camins A; Pallàs M; Pelegrí C; Vilaplana J
    Eur J Pharm Sci; 2013 Jul; 49(4):556-64. PubMed ID: 23748097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody.
    Pardridge WM
    Expert Opin Drug Deliv; 2015 Feb; 12(2):207-22. PubMed ID: 25138991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody.
    Faresjö R; Sehlin D; Syvänen S
    Fluids Barriers CNS; 2023 May; 20(1):34. PubMed ID: 37170266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular architecture determines brain delivery of a transferrin receptor-targeted lysosomal enzyme.
    Arguello A; Mahon CS; Calvert MEK; Chan D; Dugas JC; Pizzo ME; Thomsen ER; Chau R; Damo LA; Duque J; Fang M; Giese T; Kim DJ; Liang N; Nguyen HN; Solanoy H; Tsogtbaatar B; Ullman JC; Wang J; Dennis MS; Diaz D; Gunasekaran K; Henne KR; Lewcock JW; Sanchez PE; Troyer MD; Harris JM; Scearce-Levie K; Shan L; Watts RJ; Thorne RG; Henry AG; Kariolis MS
    J Exp Med; 2022 Mar; 219(3):. PubMed ID: 35226042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.